From a technical perspective, Bilibili (BILI) is looking like an interesting pick, as it just reached a key level of support. BILI recently overtook the 200-day moving average, and this suggests a ...

Bilibili (BILI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The latest price target for Bilibili (NASDAQ:BILI) was reported by HSBC on May 21, 2025. The analyst firm set a price target for $22.50 expecting BILI to rise to within 12 months (a possible 5.24% ...

A network meta-analysis published in the Journal of Dermatological Treatment found that phototherapy combined with topical antioxidants, corticosteroids, or calcineurin inhibitors was associated with ...

When rebound hyperbilirubinemia is detected, immediate reinitiation of phototherapy is recommended. In some cases, hyperbilirubinemia can return more than once. According to one study, 20.3% of ...

Below is Validea's guru fundamental report for BILIBILI INC - ADR (BILI). Of the 22 guru strategies we follow, BILI rates highest using our Quantitative Momentum Investor model based on the ...

而 Bili-Hardcore 的诞生，让AI模型接管答题全流程，成为硬核会员认证的“作弊级”工具。 工具核心功能：从登录到提交，全自动闭环 无需OCR识别，直接调用B站接口获取题目，精准匹配答案，准确率显著高于传统脚本工具。

Review quarterly and annual revenue, net income, and cash flow for Bilibili Inc ADR (BILI:XNAS) stock through the last fiscal year.

With the validation dataset, AUC values were comparable between the nomogram and AJCC staging alone (P =.804), with the nomogram having an AUC of 0.71 (95% CI, 0.51-0.91) and AJCC staging alone ...

Check out our BILI stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today. BILI - Bilibili Inc ADR Chart ...